BB-008
/ Bullet Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 22, 2023
A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=42 | Recruiting | Sponsor: BrodenBio Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1